Now may be a good time for manufacturers to seek a delay in the US Food and Drug Adminstration's enforcement of a provision in the Drug Supply Chain Security Act that requires setting up verification return systems by this November, given the agency's need to devote significant attention to COVID-19 pandemic-related activities.
That's the conclusation of Tish Eggleston Pahl, a principal attorney with the Washington food and drug law firm Olsson Frank...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?